Influence of Obstructive Sleep Apnea on systemic inflammation in pregnancy

A. Herranz Mochales (Palma, Spain), C. Ribot Quetglas (Palma, Spain), M. Barceló Nicolau (Palma, Spain), A. Álvarez Ruiz De Larriaga (Vitoria, Spain), A. Barceló Bennasar (Palma, Spain), A. Iglesias Coma (Palma, Spain), D. Morell Garcia (Palma, Spain), M. De La Peña Bravo (Palma, Spain), J. Peña Zarza (Palma, Spain), M. Bosch Artigues (Palma, Spain), M. Giménez Carrero (Palma, Spain), J. Durán Cantolla (Vitoria, Spain), J. Marín Trigo (Zaragoza, Spain), M. Codina Marcet (Palma, Spain), P. Rodríguez Rodríguez (Vitoria, Spain), C. Pía Martínez (Vitoria, Spain), M. Piñas Cebrián (Palma, Spain), M. Cerdà Moncadas (Palma, Spain), A. Sánchez Barón (Zaragoza, Spain), A. Alonso Fernández (Palma, Spain)

Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Session: From pathophysiology to clinical consequences of sleep and breathing disorders
Session type: E-poster session
Number: 2544
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Herranz Mochales (Palma, Spain), C. Ribot Quetglas (Palma, Spain), M. Barceló Nicolau (Palma, Spain), A. Álvarez Ruiz De Larriaga (Vitoria, Spain), A. Barceló Bennasar (Palma, Spain), A. Iglesias Coma (Palma, Spain), D. Morell Garcia (Palma, Spain), M. De La Peña Bravo (Palma, Spain), J. Peña Zarza (Palma, Spain), M. Bosch Artigues (Palma, Spain), M. Giménez Carrero (Palma, Spain), J. Durán Cantolla (Vitoria, Spain), J. Marín Trigo (Zaragoza, Spain), M. Codina Marcet (Palma, Spain), P. Rodríguez Rodríguez (Vitoria, Spain), C. Pía Martínez (Vitoria, Spain), M. Piñas Cebrián (Palma, Spain), M. Cerdà Moncadas (Palma, Spain), A. Sánchez Barón (Zaragoza, Spain), A. Alonso Fernández (Palma, Spain). Influence of Obstructive Sleep Apnea on systemic inflammation in pregnancy. 2544

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Obstructive Sleep Apnea severity and lung function
Source: International Congress 2018 – Diagnostics including questionnaires
Year: 2018


Prevalence of Obstructive Sleep Apnea in Idiopathic Pulmonary fibrosis
Source: International Congress 2018 – Obesity: comorbidities
Year: 2018

Smoking habits of patients with Obstructive Sleep Apnea Syndrome.
Source: International Congress 2019 – Challenges in tobacco control and cessation
Year: 2019

Metabolic changes and inflammation in obstructive sleep apnea
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014

Diagnosis of Moderate-to-severe Obstructive Sleep Apnea Syndrome based on the Sleep clinical record.
Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children
Year: 2019


Evaluation of inflammatory markers in a large sample of Obstructive Sleep Apnea Patients.
Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Year: 2017

Obstructive Sleep Apnoea is a Pulmonary Embolism severity risk factor.
Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Year: 2017

Can hemoptysis be the presenting symptom of Obstructive Sleep Apnea?
Source: International Congress 2019 – CCC Sleep and breathing disorders
Year: 2019



Asthma  and  Obstructive Sleep Apnea Syndrome (OSAS)
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018


The role of positive airway pressure treatment for Obstructive Sleep Apnea in Pulmonary Embolism
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Obstructive sleep apnoea is associated with the increased prothrombotic state
Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing
Year: 2014


Thyroid Functions in Obstructive Sleep Apnea Patients
Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Year: 2021


Daytime approach to Obstructive Sleep Apnea phenotyping
Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases
Year: 2020

Obstructive Sleep Apnea Syndrome clinical presentation  in elderly patients
Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea
Year: 2020


Obstructive sleep apnea is associated with alterations in markers of feto-placental wellbeing
Source: Annual Congress 2013 –A paediatric palimpsest: sleep apnoea from conception to the teenage years
Year: 2013


Circulating Branched-Chain Aminoacids in children with Obstructive Sleep Apnea.
Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep?
Year: 2017

Smoking in Obstructive Sleep Apnea Syndrome: gender differences
Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Year: 2020


The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19
Source: Sleep and Breathing Conference 2021
Year: 2021




Can the Sleep Clinical Record diagnose moderate-to-severe Obstructive Sleep Apnea Syndrome in children?
Source: Virtual Congress 2021 – Respiratory physiology and breathing during sleep in health and sickness
Year: 2021


Obstructive sleep apnoea syndrome and a calculation of cardiovascular risk
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014